NRBO News and Press, NeuroBo Pharmaceuticals Inc. From 09/12/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today’s price action in  NeuroBo  (NASDAQ: NRBO ) is quite remarkable, to say the least. While many stocks in the market are up today, few have seen triple-digit increases like this clinical-stage biote...

NeuroBo Pharmaceuticals ( NASDAQ: NRBO ) shares are surging 56% on announcing a 1-for-30 reverse split of its common stock, par value $0.001. The trading on a split adjusted basis will commence on Nasdaq from September 13, 2022. The number of authorized shares of t...

NeuroBo Pharmaceuticals Announces Reverse Stock Split PR Newswire BOSTON , Sept. 12, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) ("NeuroBo" or the "Company"), a clinical-stage biotechnology company, announced today a 1-for-30 reverse...

NeuroBo Pharmaceuticals, Inc. Expands Management Team with the Appointment of Matthew Bardin, PharmD, BCPS as Senior Vice President Operations PR Newswire BOSTON , May 6, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-st...

NeuroBo Pharmaceuticals press release (NASDAQ:NRBO): FY GAAP EPS of -$0.66. Cash and Cash Equivalents were $16.4 million as of December 31, 2021, compared with $10.1 million as of December 31, 2020. For further details see: NeuroBo Pharmaceuticals GAAP EPS of -$0.66

NeuroBo Pharmaceuticals Reports Full Year 2021 Financial Results PR Newswire BOSTON , April 1, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced financial results for the year en...

NeuroBo Pharmaceuticals, Inc. Expands Scientific Advisory Board with Appointment of Danamarie Belpulsi, M.D. PR Newswire BOSTON , March 15, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announ...

Gainers: BioCardia BCDA +32%. Biophytis BPTS +17%. Mersana Therapeutics MRSN +7%. Liquidia (NASDAQ:LQDA) +5%. Vaccitech (NASDAQ:VACC) +3%. Losers: Kiromic BioPharma KRBP -17%. Mainz Biomed (NASDAQ:MYNZ) -9%. Vaccinex (NASDAQ:VCNX) -7%. NeuroBo Phar...

NeuroBo Pharmaceuticals, Inc. Appoints D. Gordon Strickland to its Board of Directors PR Newswire BOSTON , Jan. 28, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment of D...

Buying Penny Stocks Today? Here’s What You Need to Know As we enter another week of trading penny stocks and blue chips, there is a lot to know. Right now, we’re witnessing the stock market post more potential signs of a negative trading day as well as a further crash with...